Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing highly-pure bendamustine hydrochloride

A technology of bendamustine hydrochloride and a synthesis method, which is applied in the field of synthesis of bendamustine hydrochloride, can solve the problems of inability to synthesize, be difficult to purify, and have many impurities, and achieve a short synthesis period, easy separation, and few impurities. Effect

Active Publication Date: 2011-04-13
深圳万乐药业有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] It has been proved by experiments that using SOCl in this reaction 2 The reaction of chlorination produces more impurities, which are not easy to purify, and the process disclosed in this document cannot be synthesized to obtain bendamustine hydrochloride reaching the chemical raw material drug impurity level (single impurity less than 0.1%) required by the state

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing highly-pure bendamustine hydrochloride
  • Method for synthesizing highly-pure bendamustine hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] 1) Synthesis of [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole

[0019] Stir and dissolve [1-methyl-2(4'-butanoic acid ethyl)-5-amino]-1H-benzimidazole (150g, 0.58mol), water 1500mL, and glacial acetic acid 750mL in a 3L reaction flask, Cool to -5~0°C, add 300mL ethylene oxide, and control the temperature until the reaction is complete. Adjust the pH to 7.1-7.3 with saturated potassium carbonate solution, extract with 800 mL×3 dichloromethane, combine the organic phases, wash with saturated brine 600 mL×3, and dry over anhydrous magnesium sulfate. Suction filtration and concentration gave a brown oily solid.

[0020] 2) Chlorination reaction to synthesize [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-chloroethyl)]-1H-benzimidazole

[0021] [1-Methyl-2(4'-butanoic acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole (200g, 0.56mol), xylene 800mL, phosphorus oxychloride 500mL mixed, heated to reflux for 8h. Allow to cool, and con...

Embodiment 2

[0029] 1) Synthesis of [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole

[0030] Stir and dissolve [1-methyl-2(4'-butanoic acid ethyl)-5-amino]-1H-benzimidazole (150g, 0.58mol), water 1500mL, and glacial acetic acid 750mL in a 3L reaction flask, Cool to -5~0°C, add 250mL ethylene oxide, and control the temperature until the reaction is complete. Adjust the pH to 7.1-7.3 with saturated potassium carbonate solution, extract with 800 mL×3 dichloromethane, combine the organic phases, wash with saturated brine 600 mL×3, and dry over anhydrous magnesium sulfate. Suction filtration and concentration gave a brown oily solid.

[0031] 2) Chlorination reaction to synthesize [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-chloroethyl)]-1H-benzimidazole

[0032] [1-Methyl-2(4'-butanoic acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole (200g, 0.56mol), toluene 1000mL , phosphorus oxychloride 800mL mixed, heated to reflux for 3h. Allow to cool, and ...

Embodiment 3

[0038] 1) Synthesis of [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole

[0039] Stir and dissolve [1-methyl-2(4'-butanoic acid ethyl)-5-amino]-1H-benzimidazole (150g, 0.58mol), water 1500mL, and glacial acetic acid 750mL in a 3L reaction flask, Cool to -5~0°C, add 400mL ethylene oxide, and control the temperature until the reaction is complete. Adjust the pH to 7.1-7.3 with saturated potassium carbonate solution, extract with 800 mL×3 dichloromethane, combine the organic phases, wash with saturated brine 600 mL×3, and dry over anhydrous magnesium sulfate. Suction filtration and concentration gave a brown oily solid.

[0040] 2) Chlorination reaction to synthesize [1-methyl-2(4'-butyric acid ethyl)-5-N,N-bis(2'-chloroethyl)]-1H-benzimidazole

[0041] [1-Methyl-2(4'-butanoic acid ethyl)-5-N,N-bis(2'-hydroxyethyl)]-1H-benzimidazole (200g, 0.56mol), xylene 800mL, phosphorus oxychloride 1000mL mixed, heated to reflux for 5h. Allow to cool, and co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing highly-pure bendamustine hydrochloride, which comprises the following steps: taking [1-methy-2(4'-ethyl butyrate)-5-amino]-1H-benzimidazole as a raw material; and orderly reacting the [1-methy-2(4'-ethyl butyrate)-5-amino]-1H-benzimidazole with ethylene oxide and phosphorus oxychloride through the four steps of substitution, hydrolysis, salification and refinement so as to produce the bendamustine hydrochloride. The method in the invention is mild in condition, simple in operation, short in synthesis period and suitable for scaled-up industrial production; and the purity of the synthesized bendamustine hydrochloride is over 99.5 percent, while monomeric impurity is below 0.1 percent, which meet the quality standards of raw material medicament.

Description

technical field [0001] The invention relates to a synthesis method of a chemical raw material medicine, in particular to a synthesis method of high-purity bendamustine hydrochloride. Background technique [0002] Bendamustine hydrochloride (bendamustine hydrochloride) is a bifunctional alkylating agent, which can cause DNA single-strand and double-strand cross-linking through alkylation, disrupt the function of DNA and DNA synthesis, and make the relationship between DNA and protein Between, and cross-linking between proteins, thus exerting anti-tumor effect. From 1971 to 1992, bendamustine hydrochloride was produced by Jenapharm under the trade name Cytostasan. After 1993, it was marketed in Germany under the trade name Ribomustine by Ribosepharm for the treatment of breast cancer and chronic lymphocytic leukemia. On March 20, 2008, bendamustine hydrochloride developed by Cephalon was approved by the US FDA for the treatment of chronic lymphocytic leukemia (CLL), with the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D235/16
Inventor 王先登刘立力张广明
Owner 深圳万乐药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com